Ticker

Catheter Precision, Inc. (NYSEAMERICAN:VTAK - Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totaling 80,782 shares, a growth of 91.9% from the March 31st total of 42,085 shares. Approximately 3.2% of the shares of the stock are sold short. Based on an average

Major Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility Flyte Expands Focus on High-Frequency Short-Haul Routes to Capture Surging Demand as Industry Economics Continue to Shift FORT MILL, S.C., April 20, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), today announced it is…

FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) --  Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention Device for Large-Bore Venous Access Closure” has been accepted by the Journal of Interventional Cardiac Electrophysiology (JICE), a leading medical journal in the field of electrophysiology.

Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year

Catheter Precision (NYSEAMERICAN:VTAK - Get Free Report) will likely be releasing its results before the market opens on Friday, March 27th. Analysts expect Catheter Precision to post earnings of ($20.90) per share and revenue of $1.70 million for the quarter. Catheter Precision Stock Performance VTAK stock opened at $1.31 on Friday. The stock has a